|
|
|
|
Дата |
|---|
| 31.08.2026 |
| 28.08.2026 |
| 27.08.2026 |
| 26.08.2026 |
| 25.08.2026 |
| 24.08.2026 |
| 21.08.2026 |
| 20.08.2026 |
| 19.08.2026 |
| 18.08.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
233.50
|
233.50
|
236.00
|
233.50
|
|
|
941 287.00
|
|
|
|
|
235.00
|
233.00
|
235.00
|
234.00
|
|
|
2 022 270.00
|
|
|
|
|
234.50
|
233.00
|
237.50
|
235.00
|
|
|
1 349 943.25
|
|
|
|
|
235.00
|
233.00
|
238.00
|
234.50
|
|
|
2 118 592.25
|
|
|
|
|
236.50
|
232.00
|
236.50
|
234.50
|
|
|
2 959 163.25
|
|
|
|
|
238.50
|
232.00
|
238.50
|
236.50
|
|
|
2 602 290.75
|
|
|
|
|
243.50
|
236.00
|
245.00
|
238.50
|
|
|
2 314 048.00
|
|
|
|
|
250.00
|
242.00
|
250.00
|
243.50
|
|
|
1 975 906.75
|
|
|
|
|
249.00
|
245.00
|
250.00
|
250.00
|
|
|
990 633.00
|
|
|
|
|
250.00
|
247.00
|
250.50
|
249.00
|
|
|
435 695.00
|
|
Период |
|---|
| 2025, регулярные |
| 2024, регулярные |
| 2023, регулярные |
| 2022, регулярные |
| 2021, регулярные |
| 2021, регулярные |
| 2020, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2018, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
17.06.2026
|
18.06.2026 |
9 CHF |
|
02.07.2025
|
03.07.2025 |
4.9 CHF |
|
07.08.2024
|
08.08.2024 |
7.5 CHF |
|
03.08.2023
|
04.08.2023 |
7.5 CHF |
|
30.08.2022
|
31.08.2022 |
9.7 CHF |
|
07.09.2021
|
08.09.2021 |
12.5 CHF |
|
08.09.2020
|
09.09.2020 |
7.7 CHF |
|
10.09.2019
|
11.09.2019 |
7.5 CHF |
|
19.09.2018
|
20.09.2018 |
1.5 CHF |
|
27.06.2018
|
28.06.2018 |
5.5 CHF |
HBM Healthcare Investments actively invests in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas. The company holds and manages an international portfolio of some twenty five promising companies. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided on their strategic directions. This is what makes HBM Healthcare Investments an interesting alternative to investing in big pharma and biotech companies. HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker: HBMN).
